Lortab and Etoposide drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Lortab (acetaminophen; hydrocodone bitartrate) and Etoposide (etoposide). Common drug interactions include blood sodium decreased among females and hypotension among males.

The phase IV clinical study analyzes what interactions people have when they take Lortab and Etoposide. It is created by eHealthMe based on reports of 46 people who take the same drugs from the FDA, and is updated regularly.

What is Lortab?

Lortab has active ingredients of acetaminophen; hydrocodone bitartrate. It is often used in pain. eHealthMe is studying from 31,285 Lortab users. Check the latest studies of Lortab.

What is Etoposide?

Etoposide has active ingredients of etoposide. eHealthMe is studying from 77,815 Etoposide users. Check the latest studies of Etoposide.

On Jul, 19, 2026

46 people who take Lortab and Etoposide together, and have interactions are studied.

What are the common drug interactions of Lortab and Etoposide, by gender? *:

female:

Blood sodium decreased
Dehydration (dryness resulting from the removal of water)
Febrile neutropenia (fever with reduced white blood cells)
Haematocrit decreased
Pain in extremity
Pancreatitis (inflammation of pancreas)
Pulmonary mycosis (lung infection caused by yeast-like fungi)
Septic embolus (a type of embolism that is infected with bacteria)
Weight decreased
Alanine aminotransferase increased

male:

Hypotension (abnormally low blood pressure)
Neutropenia (an abnormally low number of neutrophils)
Ventricular extrasystoles (premature cardiac contraction)
Anxiety
Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)
Constipation
Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
Dyspnoea (difficult or laboured respiration)
Gastrointestinal haemorrhage (bleeding gastrointestinal tract)

What are the common drug interactions of Lortab and Etoposide, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

Abscess limb (limb infection)
Candidiasis (candidiasis or thrush is a fungal infection)
Cardiac arrest
Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)
Device related infection
Dyspnoea (difficult or laboured respiration)
Escherichia infection (bacterial infection by escherichia coli)
Fungal infection
Hypertension (high blood pressure)
Hypotension (abnormally low blood pressure)

20-29:

Blood magnesium decreased
Blood sodium decreased
Dehydration (dryness resulting from the removal of water)
Febrile neutropenia (fever with reduced white blood cells)
Haematocrit decreased
Haemoglobin decreased
Hypokalaemia (low potassium)
Pain in extremity
Pancreatitis (inflammation of pancreas)
Pulmonary mycosis (lung infection caused by yeast-like fungi)

30-39:

n/a

40-49:

Pyrexia (fever)
Alopecia (absence of hair from areas of the body)
Blood urine present
Bone pain
Catheter site infection (infection at the site of insertion)
Cough
Dyspnoea (difficult or laboured respiration)
Hypoacusis (loss of hearing)
Neutropenia (an abnormally low number of neutrophils)
Purulence (containing pus)

50-59:

Cardio-respiratory arrest (sudden dysfunction of heart and lungs)
Dehydration (dryness resulting from the removal of water)
Otitis media (inflammation of the middle ear)
Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)
Anxiety
Arteriosclerosis (thickening and hardening of arteries)
Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)
Constipation
Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)

60+:

Thrombocytopenia (decrease of platelets in blood)
Asthenia (weakness)
Cardiac arrest
Cholelithiasis (the presence or formation of gallstones in the gallbladder or bile ducts)
Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)
Decreased appetite
Dehydration (dryness resulting from the removal of water)
Dysphasia (language disorder marked by deficiency in the generation of speech)
Exfoliative rash (scaly red generalized skin rash)
Eye discharge

What are the existing conditions these people have? *

Multiple Myeloma (cancer of the plasma cells): 7 people, 15.22%
Acute Lymphocytic Leukemia (All) (cancer of the white blood cells characterized by excess lymphoblasts): 5 people, 10.87%
Adenocarcinoma (malignant tumour formed from glandular structures in epithelial tissue): 4 people, 8.70%
Small Cell Lung Cancer Stage Unspecified (lung cancer in unknown stage): 3 people, 6.52%
High Blood Pressure: 3 people, 6.52%
Glioblastoma Multiforme (most common and deadliest of malignant primary brain tumours in adults): 3 people, 6.52%

* Approximation only. Some reports may have incomplete information.

Do you take Lortab and Etoposide?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously